Should GLP-1 Receptor Agonists Be the First Line of Treatment for Type 2 Diabetes?

Diabetes Technology& Therapeutics Nov 2016, Vol. 18, No. 11: 671-673.
Source: Diabetes Technology - Category: Endocrinology Authors: Source Type: research